News & Updates
Filter by Specialty:
Nadofaragene firadenovec promotes bladder preservation in BCG-unresponsive NMIBC
Nadofaragene firadenovec-vncg helps preserve the bladder in patients with bacillus Calmette-Guérin (BCG)-unresponsive nonmuscle-invasive bladder cancer (NMIBC) at 5 years, with an acceptable safety profile, as shown in a phase III trial.
Nadofaragene firadenovec promotes bladder preservation in BCG-unresponsive NMIBC
05 Jul 2024
Bladder cancer survivors who do not smoke enjoy better life quality
Among patients with bladder cancer (BC), those who do not smoke appear to have better longitudinal health-related quality of life (HRQoL) measures, particularly in the domains of physical function, emotional function, and fatigue, according to a recent study.
Bladder cancer survivors who do not smoke enjoy better life quality
04 Jul 2024
Intense exercise safe for men with metastatic prostate cancer
Patients with metastatic prostate cancer can safely engage in intense exercise training to improve survival outcomes, suggests a study presented at AACR 2024.
Intense exercise safe for men with metastatic prostate cancer
13 Jun 2024
ART discontinuation tied to toxicity, disease progression in mCRPC patients
Several patients with metastatic castration-resistant prostate cancer (mCRPC) discontinue the use of androgen receptor‒targeted therapies (ARTs) because of disease progression, while a few stopped ARTs due to treatment toxicity, according to a study.